Total Payments
$2,500
2024 Payments
$382.81
Companies
24
Transactions
148
Medicare Patients
4,734
Medicare Billing
$474,966
Payment Breakdown by Category
Food & Beverage$2,500 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,500 | 148 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $488.05 | 25 | $0 (2023) |
| GlaxoSmithKline, LLC. | $399.76 | 21 | $0 (2024) |
| Amgen Inc. | $208.68 | 14 | $0 (2024) |
| Abbott Laboratories | $188.34 | 12 | $0 (2023) |
| ABBVIE INC. | $181.30 | 8 | $0 (2024) |
| Lilly USA, LLC | $176.98 | 13 | $0 (2024) |
| Novo Nordisk Inc | $171.23 | 12 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $146.99 | 9 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.33 | 5 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $78.15 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $382.81 | 21 | GlaxoSmithKline, LLC. ($143.81) |
| 2023 | $624.95 | 34 | GlaxoSmithKline, LLC. ($148.99) |
| 2022 | $567.71 | 33 | AstraZeneca Pharmaceuticals LP ($136.78) |
| 2021 | $480.07 | 29 | AstraZeneca Pharmaceuticals LP ($131.89) |
| 2020 | $263.70 | 18 | Novo Nordisk Inc ($83.59) |
| 2019 | $181.04 | 13 | SANOFI-AVENTIS U.S. LLC ($44.14) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Bone Health | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Durable Pump | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VACCINES | ||||||
| 03/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Diabetes | ||||||
| 02/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: VACCINES | ||||||
| 02/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.43 | General |
| 11/30/2023 | Merck Sharp & Dohme LLC | M-M-R II (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: VACCINE | ||||||
| 11/29/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,023 | 4,080 | $508,413 | $155,015 |
| 2022 | 19 | 1,253 | 3,435 | $445,771 | $142,915 |
| 2021 | 22 | 1,310 | 2,062 | $274,908 | $108,516 |
| 2020 | 18 | 1,148 | 1,931 | $193,355 | $68,520 |
Total Patients
4,734
Total Services
11,508
Medicare Billing
$474,966
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 315 | 622 | $155,908 | $54,822 | 35.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 36 | 2,640 | $227,172 | $47,624 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 220 | 220 | $54,560 | $28,131 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 155 | $28,030 | $8,943 | 31.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 59 | 59 | $4,814 | $4,456 | 92.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 20 | $8,440 | $2,783 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $9,030 | $1,779 | 19.7% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 11 | 11 | $1,705 | $1,573 | 92.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $1,236 | $1,162 | 94.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,102 | $868.28 | 21.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 16 | $3,616 | $813.80 | 22.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 78 | $5,644 | $783.61 | 13.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 11 | 11 | $704.00 | $449.23 | 63.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,122 | $412.72 | 36.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $228.00 | $221.24 | 97.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 26 | $988.00 | $108.49 | 11.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 74 | $666.00 | $60.25 | 9.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 28 | $448.00 | $25.75 | 5.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 403 | 753 | $187,497 | $65,734 | 35.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 24 | 1,440 | $123,912 | $25,230 | 20.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 181 | 181 | $44,888 | $23,970 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 184 | $31,280 | $10,965 | 35.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 62 | 62 | $4,564 | $4,138 | 90.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $15,960 | $4,004 | 25.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 25 | 38 | $4,218 | $1,654 | 39.2% |
About Dr. Christopher Prior, D.O
Dr. Christopher Prior, D.O is a Sports Medicine healthcare provider based in Sheridan, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487670717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Prior, D.O has received a total of $2,500 in payments from pharmaceutical and medical device companies, with $382.81 received in 2024. These payments were reported across 148 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,500).
As a Medicare-enrolled provider, Prior has provided services to 4,734 Medicare beneficiaries, totaling 11,508 services with total Medicare billing of $474,966. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine, Sports Medicine
- Location Sheridan, WY
- Active Since 07/13/2006
- Last Updated 10/20/2025
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1487670717
Products in Payments
- FARXIGA (Drug) $229.62
- TRELEGY ELLIPTA (Drug) $195.67
- EVENITY (Biological) $143.61
- Ozempic (Drug) $131.17
- AREXVY (Drug) $116.51
- FREESTYLE LIBRE 2 (Device) $103.55
- MOUNJARO (Drug) $99.89
- BREZTRI (Drug) $92.66
- TRINTELLIX (Drug) $78.15
- QULIPTA (Drug) $76.24
- SHINGRIX (Biological) $72.87
- SOLIQUA 100/33 (Biological) $61.69
- UBRELVY (Drug) $55.14
- ELIQUIS (Drug) $54.19
- Aimovig (Biological) $51.17
- VRAYLAR (Drug) $49.92
- XARELTO (Drug) $42.09
- TOUJEO (Biological) $41.16
- TRULICITY (Drug) $38.81
- NEXPLANON (Drug) $38.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.